Acute Disseminated Encephalomyelitis Associated with Cytomegalovirus Infection in an Immunocompetent Subject
DOI:
https://doi.org/10.12974/2309-6179.2014.01.01.1Keywords:
ADEM, CMV, Immunocompetent, Gray matter.Abstract
Purpose: Fulminant acute disseminated encephalomyelitis (ADEM) associated with cytomegalovirus (CMV) infection in immunocompetent hosts is rare, and the MRI findings might be atypical. Case report: A 17-year-old immunocompetent man presented with acute flaccid paraplegia accompanied by bladder and bowel incontinence. The serum virology tests revealed the presence of CMV IgM and IgG, indicating reactivation of latent infection. MRI studies of the brain and the whole spinal cord showed diffuse gray matter lesions of hyperintense signals in T2. After aggressive rescue therapy combining intravenous immunoglobulin, pulse methylprednisolone and plasma exchange, the patient made a complete neurological recovery 6 months later. Conclusion: This report demonstrates the association of CMV infection with ADEM in an immunocompetent subject. Although the treatment regimen and timing for patients with ADEM need further investigation, aggressive rescue therapy by adopting multiple immunomodulatory treatments may be warranted.
References
Reeves M, Sinclair J. Human Cytomegalovirus. Current Topics in Microbiology and Immunology. 2008; 325: 297-313. http://dx.doi.org/10.1007/978-3-540-77349-8_17
Kanzaki A, Yabuki S. Acute disseminated encephalomyelitis (ADEM) associated with cytomegalovirus infection--a case report. Rinsho shinkeigaku. Clinical Neurology. 1994; 34(5): 511-3.
Tenembaum S, Chitnis T, Ness J, Hahn JS, International Pediatric MSSG. Acute disseminated encephalomyelitis. Neurology. 2007; 68(16 Suppl 2): S23-36.
Schwarz S, Mohr A, Knauth M, Wildemann B, Storch- Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001; 56(10): 1313-8. http://dx.doi.org/10.1212/WNL.56.10.1313
Lin C-H, Jeng J-S, Yip P-K. Plasmapheresis in acute disseminated encephalomyelitis. Journal of Clinical Apheresis. 2004; 19(3): 154-9. http://dx.doi.org/10.1002/jca.20022
Lu RP, Keilson G. Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis. Journal of Clinical Apheresis. 2006; 21(4): 260-5. http://dx.doi.org/10.1002/jca.20103
Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N. Outcome of Severe Encephalomyelitis in Children: Effect of High-Dose Methylprednisolone and Immunoglobulins. Journal of Child Neurology. 2002; 17(11): 810-4. http://dx.doi.org/10.1177/08830738020170111001
E Fridinger S, Alper G. Defining Encephalopathy in Acute Disseminated Encephalomyelitis. Journal of Child Neurology. 2013 Jun 12.
[Epub ahead of print]
Krupp LB, Banwell B, Tenembaum S, International Pediatric MSSG. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007; 68(16 Suppl 2): S7-12. http://dx.doi.org/10.1212/01.wnl.0000259422.44235.a8
Dale RC. Acute disseminated encephalomyelitis. Seminars in Pediatric Infectious Diseases. 2003; 14(2): 90-5. http://dx.doi.org/10.1053/spid.2003.127225
Monden Y, Yamagata T, Kuroiwa Y, Takahashi T, Mori M, Fukuda T, et al. A case of ADEM with atypical MRI findings of a centrally-located long spinal cord lesion. Brain and Development. 2012; 34(5): 380-3. http://dx.doi.org/10.1016/j.braindev.2011.06.010
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006; 66(10): 1485-9. http://dx.doi.org/10.1212/01.wnl.0000216139.44259.74
Wreghitt TG, Teare EL, Sule O, Devi R, Rice P. Cytomegalovirus infection in immunocompetent patients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2003; 37(12): 1603- 6. http://dx.doi.org/10.1086/379711
Brok HP, Boven L, van Meurs M, Kerlero de Rosbo N, Celebi- Paul L, Kap YS, et al. The human CMV-UL86 peptide 981- 1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys. J Neuroimmunol. 2007; 182(1-2): 135-52. http://dx.doi.org/10.1016/j.jneuroim.2006.10.010
Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, Freedman M, et al. Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions. Transfusion Medicine Reviews. 2007; 21: S57-S107. http://dx.doi.org/10.1016/j.tmrv.2007.01.002
